AARTI DRUGS
Back to Income Statement
|
AARTI DRUGS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹171 Cr | ₹166 Cr | ₹205 Cr | ₹280 Cr | ₹141 Cr |
What is the latest Consolidated Net Profit of AARTI DRUGS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹171 Cr |
| Mar2024 | ₹166 Cr |
| Mar2023 | ₹205 Cr |
| Mar2022 | ₹280 Cr |
| Mar2021 | ₹141 Cr |
How is Consolidated Net Profit of AARTI DRUGS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹171 Cr | 3.07 | |
| Mar2024 | ₹166 Cr | -18.89 | |
| Mar2023 | ₹205 Cr | -26.88 | |
| Mar2022 | ₹280 Cr | 98.31 | |
| Mar2021 | ₹141 Cr | - | |
Compare Consolidated Net Profit of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,416.9 Cr | -0.3% | -0.3% | -4.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -0.3% |
-0.3% |
-4.9% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses